Published in N Engl J Med on March 20, 1986
Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency (CBZ) | NCT01379469
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis (2009) 3.40
Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc Natl Acad Sci U S A (2000) 3.17
Diagnosis of alpha 1-antitrypsin deficiency by enzymatic amplification of human genomic DNA and direct sequencing of polymerase chain reaction products. Nucleic Acids Res (1988) 3.00
Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) (2010) 2.48
Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J Clin Invest (1990) 2.35
Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am J Pathol (2000) 2.23
Immune pathogenesis of hepatocellular carcinoma. J Exp Med (1998) 2.11
Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. J Clin Invest (2002) 1.84
Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. J Clin Invest (1989) 1.72
Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ (1997) 1.66
Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis. J Clin Invest (1999) 1.60
Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol (2005) 1.36
Multiple tissues express alpha 1-antitrypsin in transgenic mice and man. J Clin Invest (1988) 1.34
Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha-1-anti-trypsin deficiency. EMBO Mol Med (2013) 1.22
Small molecules block the polymerization of Z alpha1-antitrypsin and increase the clearance of intracellular aggregates. J Med Chem (2007) 1.21
Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology. Thorax (2004) 1.18
Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax (1998) 1.17
Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma. Cancer Lett (2009) 1.16
Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax (2004) 1.15
Hepatic fibrosis and carcinogenesis in α1-antitrypsin deficiency: a prototype for chronic tissue damage in gain-of-function disorders. Cold Spring Harb Perspect Biol (2011) 1.07
Prenatal diagnosis of alpha 1 antitrypsin deficiency and estimates of fetal risk for disease. J Med Genet (1987) 1.07
Mysteries of α1-antitrypsin deficiency: emerging therapeutic strategies for a challenging disease. Dis Model Mech (2014) 1.02
Alpha-1-antitrypsin deficiency: current concepts. Lung (2007) 1.00
Transmitting genetic risk information in families: attitudes about disclosing the identity of relatives. Am J Hum Genet (1999) 0.96
Survival in severe alpha-1-antitrypsin deficiency (PiZZ). Respir Res (2010) 0.94
Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversies. World J Gastroenterol (2013) 0.94
Diagnosis and management of patients with α1-antitrypsin (A1AT) deficiency. Clin Gastroenterol Hepatol (2011) 0.94
Synthesis of stress proteins is increased in individuals with homozygous PiZZ alpha 1-antitrypsin deficiency and liver disease. J Clin Invest (1989) 0.93
Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ). Thorax (2002) 0.93
Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline. Can Respir J (2012) 0.92
Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis. Drug Des Devel Ther (2011) 0.92
Characteristics of hepatocellular carcinoma in a murine model of alpha-1-antitrypsin deficiency. Hepatol Res (2010) 0.91
Oxidized {alpha}1-antitrypsin stimulates the release of monocyte chemotactic protein-1 from lung epithelial cells: potential role in emphysema. Am J Physiol Lung Cell Mol Physiol (2009) 0.90
Alpha 1-antitrypsin deficiency--diagnosis, treatment, and control: identification of patients. Lung (1990) 0.89
Genetic studies on a new deficiency gene (PI*Ztun) at the PI locus. J Med Genet (1989) 0.87
alpha1-Antitrypsin deficiency . 6: new and emerging treatments for alpha1-antitrypsin deficiency. Thorax (2004) 0.86
Screening for hepatocellular carcinoma. Int J Hepatol (2011) 0.86
Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma. Hepat Mon (2012) 0.86
Expression of hereditary hemochromatosis C282Y HFE protein in HEK293 cells activates specific endoplasmic reticulum stress responses. BMC Cell Biol (2007) 0.86
Misdiagnosis of α-1 antitrypsin phenotype in an infant with CMV infection and liver failure. Dig Dis Sci (2014) 0.86
Fluorescence correlation spectroscopic study of serpin depolymerization by computationally designed peptides. J Mol Biol (2007) 0.85
Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients. PLoS One (2013) 0.85
Targeting intracellular degradation pathways for treatment of liver disease caused by α1-antitrypsin deficiency. Pediatr Res (2013) 0.85
A single-chain variable fragment intrabody prevents intracellular polymerization of Z α1-antitrypsin while allowing its antiproteinase activity. FASEB J (2015) 0.84
Genetic predisposition to alcoholic liver disease. Gut (1992) 0.84
Z α-1 antitrypsin deficiency and the endoplasmic reticulum stress response. World J Gastrointest Pharmacol Ther (2010) 0.83
Capitalizing on the autophagic response for treatment of liver disease caused by alpha-1-antitrypsin deficiency and other genetic diseases. Biomed Res Int (2014) 0.83
Alpha-1-antitrypsin phenotypes in adult liver disease patients. Ups J Med Sci (2009) 0.83
Protein misfolding and the serpinopathies. Prion (2007) 0.83
Alpha-1 antitrypsin is a potential biomarker for hepatitis B. Virol J (2011) 0.83
Two New Considerations for Improving the Diagnosis of α1-Antitrypsin Deficiency-Associated Liver Disease. Dig Dis Sci (2015) 0.82
Hepatic progenitor cell proliferation and liver injury in α-1-antitrypsin deficiency. J Pediatr Gastroenterol Nutr (2010) 0.82
Activation of JNK pathway aggravates proteotoxicity of hepatic mutant Z alpha1-antitrypsin. Hepatology (2017) 0.82
Sustained knockdown of a disease-causing gene in patient-specific induced pluripotent stem cells using lentiviral vector-based gene therapy. Stem Cells Transl Med (2013) 0.82
Emergence of a stage-dependent human liver disease signature with directed differentiation of alpha-1 antitrypsin-deficient iPS cells. Stem Cell Reports (2015) 0.81
Retarded protein folding of deficient human alpha 1-antitrypsin D256V and L41P variants. Protein Sci (2004) 0.81
A genome-wide RNAi screen identifies potential drug targets in a C. elegans model of α1-antitrypsin deficiency. Hum Mol Genet (2014) 0.81
Urinary peptide profiling to differentiate between minimal change disease and focal segmental glomerulosclerosis. PLoS One (2014) 0.81
Liver test results do not identify liver disease in adults with α(1)-antitrypsin deficiency. Clin Gastroenterol Hepatol (2012) 0.81
Novel treatment strategies for liver disease due to α1-antitrypsin deficiency. Clin Transl Sci (2012) 0.81
Alpha 1-antitrypsin and survival in hepatocellular carcinoma. Br J Cancer (1990) 0.78
A novel alpha1-antitrypsin null variant (PiQ0Milano ). World J Hepatol (2013) 0.78
Non-viral causes of hepatocellular carcinoma. J Gastrointest Cancer (2011) 0.78
Characterising the association of latency with α(1)-antitrypsin polymerisation using a novel monoclonal antibody. Int J Biochem Cell Biol (2014) 0.78
1H, 15N and 13C backbone resonance assignments of the archetypal serpin α1-antitrypsin. Biomol NMR Assign (2011) 0.78
The significance of the F variant of alpha-1-antitrypsin and unique case report of a PiFF homozygote. BMC Pulm Med (2014) 0.78
Increased PiZ gene frequency for alpha 1 antitrypsin in patients with genetic haemochromatosis. Gut (1995) 0.77
Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease. World J Hepatol (2015) 0.77
Discovery of an inhibitor of Z-alpha1 antitrypsin polymerization. PLoS One (2015) 0.76
Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease. Rare Dis (2014) 0.76
A novel model and molecular therapy for Z alpha-1 antitrypsin deficiency. Mamm Genome (2011) 0.76
Dysfunctional glycogen storage in a mouse model of alpha1-antitrypsin deficiency. Am J Respir Cell Mol Biol (2008) 0.76
Aetiology and pathophysiology of chronic liver disorders. Drugs (1990) 0.76
Risk prediction models for hepatocellular carcinoma in different populations. Chin J Cancer Res (2016) 0.76
Discovery of alpha 1-antitrypsin deficiency. Lung (1990) 0.76
Context-Specific and Immune Cell-Dependent Antitumor Activities of α1-Antitrypsin. Front Immunol (2016) 0.75
Current and Emerging Treatments for Alpha-1 Antitrypsin Deficiency. Gastroenterol Hepatol (N Y) (2016) 0.75
Ubiquitin ligase SYVN1/HRD1 facilitates degradation of the SERPINA1 Z variant/α-1-antitrypsin Z variant via SQSTM1/p62-dependent selective autophagy. Autophagy (2017) 0.75
Understanding Lung Deposition of Alpha-1 Antitrypsin in Acute Experimental Mouse Lung Injury Model Using Fluorescence Microscopy. Int J Mol Imaging (2016) 0.75
Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden. Int J Chron Obstruct Pulmon Dis (2016) 0.75
α1-antitrypsin Deficiency: A Misfolded Secretory Protein Variant with Unique Effects on the Endoplasmic Reticulum. Endoplasmic Reticulum Stress Dis (2016) 0.75
Alpha-1-Antitrypsin Deficiency: An Important Cause of Pediatric Liver Disease. Lung Health Prof Mag (2016) 0.75
Liver tumors in children with metabolic disorders. Transl Pediatr (2015) 0.75
The endoplasmic reticulum remains functionally connected by vesicular transport after its fragmentation in cells expressing Z-α1-antitrypsin. FASEB J (2016) 0.75
α1-antitrypsin deficiency and the hepatocytes - an elegans solution to drug discovery. Int J Biochem Cell Biol (2013) 0.75
Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin Deficiency. PLoS One (2015) 0.75
[Hereditary hemochromatosis, alpha-1-antitrypsin deficiency and Wilson's disease. Pathogenesis, clinical findings and pathways to diagnosis]. Pathologe (2008) 0.75
Alpha(1)-Antitrypsin Deficiency. Curr Treat Options Gastroenterol (2000) 0.75
Hepatoid carcinoma of the skin: spontaneous rat skin hepatoid carcinoma with eosinophilic globules and crystals immunoreactive to alpha-1-antitrypsin. Med Mol Morphol (2009) 0.75
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
Some international comparisons of mortality amenable to medical intervention. Br Med J (Clin Res Ed) (1986) 5.33
An integrated computational pipeline and database to support whole-genome sequence annotation. Genome Biol (2002) 5.24
Localization of the human alpha-globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay. Cell (1977) 4.34
Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J (Clin Res Ed) (1988) 4.03
Cloning and sequencing of the ribosomal RNA genes in maize: the 17S region. DNA (1984) 4.02
Quality-of-life changes and hearing impairment. A randomized trial. Ann Intern Med (1990) 3.52
Effect of unilateral spinal adjustments on goniometrically-assessed cervical lateral-flexion end-range asymmetries in otherwise asymptomatic subjects. J Manipulative Physiol Ther (1989) 3.34
Mammalian deoxyribonucleoside kinases. Pharmacol Ther (1995) 3.31
Myrosinase: gene family evolution and herbivore defense in Brassicaceae. Plant Mol Biol (2000) 3.15
Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med (1989) 3.03
Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet (2001) 2.91
Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum. J Exp Med (1998) 2.83
Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut (1996) 2.79
Studies in alpha 1-antitrypsin deficiency. Acta Med Scand Suppl (1965) 2.77
The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet (2001) 2.71
Risk factors for AIDS and HIV seropositivity in homosexual men. Am J Epidemiol (1987) 2.62
Primary structure of the Escherichia coli ribonucleoside diphosphate reductase operon. Proc Natl Acad Sci U S A (1984) 2.54
A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology (1999) 2.51
Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut (2004) 2.48
Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits. J Biol Chem (1985) 2.47
Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother (2001) 2.35
Plasmodium falciparum-infected erythrocytes form spontaneous erythrocyte rosettes. J Exp Med (1989) 2.34
Collagenous colitis and fecal stream diversion. Gastroenterology (1995) 2.32
Oral immunoglobulin A supplement in treatment of Clostridium difficile enteritis. Lancet (1993) 2.22
Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis. J Biol Chem (1984) 2.19
Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. J Biol Chem (1991) 2.19
Bacterial genome size reduction by experimental evolution. Proc Natl Acad Sci U S A (2005) 2.13
Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J Immunol (1987) 2.09
Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J Virol (1994) 2.07
Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am J Trop Med Hyg (1992) 2.06
Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. Eur Respir J (2001) 1.97
The liver in adolescents with alpha 1-antitrypsin deficiency. Hepatology (1995) 1.95
Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J (2006) 1.93
Ribonucleotide reductase from calf thymus. Purification and properties. Biochemistry (1979) 1.90
Moderate exercise during growth in prepubertal boys: changes in bone mass, size, volumetric density, and bone strength: a controlled prospective study. J Bone Miner Res (1998) 1.88
Cost-effectiveness of alternative methods for diabetic retinopathy screening. Diabetes Care (1992) 1.86
Trapped antihydrogen. Nature (2010) 1.85
Systematic review: microscopic colitis. Aliment Pharmacol Ther (2006) 1.81
Ribonucleotide reductase from calf thymus. Separation of the enzyme into two nonidentical subunits, proteins M1 and M2. J Biol Chem (1980) 1.78
Allosteric regulation of calf thymus ribonucleoside diphosphate reductase. Biochemistry (1979) 1.76
Liver disease in adults with alpha-1 -antitrypsin deficiency. N Engl J Med (1972) 1.75
Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res (1983) 1.74
Validation of self-reported breast and cervical cancer screening tests among low-income minority women. Cancer Epidemiol Biomarkers Prev (1996) 1.72
Association between hearing impairment and the quality of life of elderly individuals. J Am Geriatr Soc (1990) 1.65
Collagenous colitis in Orebro, Sweden, an epidemiological study 1984-1993. Gut (1995) 1.64
Familial occurrence of microscopic colitis: a report on five families. Scand J Gastroenterol (2001) 1.64
The comet assay: mechanisms and technical considerations. Mutat Res (1996) 1.62
Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet (1991) 1.60
Parental Stressor Scale: neonatal intensive care unit. Nurs Res (1993) 1.60
Genetic analysis of olfactory behavior in Drosophila: a new screen yields the ota mutants. Genetics (1989) 1.59
Cancer screening behaviors of low-income women: the impact of race. Womens Health (1998) 1.58
Community-based interventions to improve breast and cervical cancer screening: results of the Forsyth County Cancer Screening (FoCaS) Project. Cancer Epidemiol Biomarkers Prev (1999) 1.58
Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease. Biol Psychiatry (1996) 1.56
Carcinoma and possible precancerous changes of the gastric stump after billroth II resection. Gastroenterology (1977) 1.56
Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut (2004) 1.56
Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria--an epidemiological investigation. Br J Cancer (1984) 1.56
Liver, lung and malignant disease in heterozygous (Pi MZ) alpha1-antitrypsin deficiency. Acta Med Scand (1975) 1.55
Screening for diabetic retinopathy. The wide-angle retinal camera. Diabetes Care (1993) 1.55
Ribonucleoside diphosphate reductase from Escherichia coli. An immunological assay and a novel purification from an overproducing strain lysogenic for phage lambdadnrd. J Biol Chem (1977) 1.52
Emergency medical transport of the elderly: a population-based study. Am J Emerg Med (1995) 1.50
smellblind: a gene required for Drosophila olfaction. Genetics (1990) 1.50
Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J (1984) 1.50
Ribonucleoside diphosphate reductase (Escherichia coli). Methods Enzymol (1978) 1.49
Blood group A antigen is a coreceptor in Plasmodium falciparum rosetting. Infect Immun (2000) 1.49
Characterization of the larval olfactory response in Drosophila and its genetic basis. Behav Genet (1989) 1.49
Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study. Epilepsia (1996) 1.47
Obstructive lung disease and trypsin inhibitors in alpha-1-antitrypsin deficiency. Scand J Clin Lab Invest (1967) 1.46
Confirming the diagnosis of mild hypertension. Br Med J (Clin Res Ed) (1983) 1.46
Cloning and sequence of DNA encoding structural proteins of the autonomous parvovirus feline panleukopenia virus. J Virol (1985) 1.45
Deoxycytidine kinase is constitutively expressed in human lymphocytes: consequences for compartmentation effects, unscheduled DNA synthesis, and viral replication in resting cells. Exp Cell Res (1988) 1.45
Hepatitis C in chronic liver disease: an epidemiological study based on 566 consecutive patients undergoing liver biopsy during a 10-year period. J Intern Med (1992) 1.44
Alpha-1-antitrypsin is present in the specific granules of human eosinophilic granulocytes. Clin Exp Allergy (2001) 1.44
Hepatocyte inclusions of alpha 1-antichymotrypsin in a patient with partial deficiency of alpha 1-antichymotrypsin and chronic liver disease. Histopathology (1990) 1.44
IgE elevation and IgE anti-malarial antibodies in Plasmodium falciparum malaria: association of high IgE levels with cerebral malaria. Clin Exp Immunol (1994) 1.44
Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study. Scand J Gastroenterol (1997) 1.44
An examination of nursing attitudes and pain management practices. Cancer Pract (1998) 1.43
Acrylamide: a cooking carcinogen? Chem Res Toxicol (2000) 1.40
Hemoglobinopathies affect hemoglobin A1C measurement. Ann Intern Med (1991) 1.40
Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J (1995) 1.38
[The influence of bear acid on lipid metabolism. A future drug?]. Lakartidningen (1995) 1.38
A simple chemosensory response in Drosophila and the isolation of acj mutants in which it is affected. Proc Natl Acad Sci U S A (1989) 1.38
A non-intensive stroke unit reduces functional disability and the need for long-term hospitalization. Stroke (1985) 1.37
Olfactory physiology in the Drosophila antenna and maxillary palp: acj6 distinguishes two classes of odorant pathways. J Neurobiol (1992) 1.37
[More accurate diagnosis could identify patients suitable for tacrine therapy]. Lakartidningen (1996) 1.37
Intracellular metabolism of 3'-azidothymidine in isolated human peripheral blood mononuclear cells. AIDS Res Hum Retroviruses (1991) 1.37
Influence of gender, race, and education on patient preferences and receipt of cardiac catheterizations among coronary care unit patients. Am J Cardiol (1996) 1.36
Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol (1997) 1.36
Characterization of alpha1-antitrypsin in the inclusion bodies from the liver in alpha 1-antitrypsin deficiency. N Engl J Med (1975) 1.35
Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates. FEBS Lett (1999) 1.34
Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ). Thorax (1997) 1.33
The effects of hemoglobin genotype and ABO blood group on the formation of rosettes by Plasmodium falciparum-infected red blood cells. Am J Trop Med Hyg (1993) 1.33
Increasing trends of multiple myeloma mortality in England and Wales; 1950-79: are the changes real? J Natl Cancer Inst (1982) 1.33
Resonant quantum transitions in trapped antihydrogen atoms. Nature (2012) 1.32
Infection by Helicobacter pylori expressing the BabA adhesin is influenced by the secretor phenotype. J Pathol (2008) 1.26
Mechanism of the effects of furosemide on renin secretion in anesthetized dogs. Circ Res (1969) 1.26
Late precancerous changes and carcinoma of the gastric stump after Billroth I resection. Am J Surg (1976) 1.25
Efficacy of computerized decision support for mechanical ventilation: results of a prospective multi-center randomized trial. Proc AMIA Symp (1999) 1.25
Description and first application of a new technique to measure the gravitational mass of antihydrogen. Nat Commun (2013) 1.25